Member Info for gtc1507

Here’s hoping for a fantastic open tomorrow.

Zak Mir has 10p as the next target after 7 and then upwards to 30 beyond that! 🥳

Paul Ws £1m buy years back….unless he’s got 100ms in the bank lol!! Today this is a no brainer but

That was a delusional purchase IMO….but each to their own and doesn’t change the fundamentals of where we are now, primed for a decent recovery

Explains why no one else could buy any substantial around that time

Https://x.com/sharesocuk/status/1850858801643049353?s=46

Definitely feels ready to test 7 and above.

https://x.com/darrenukdaytra1/status/1866436738060853282?s=46

Https://x.com/zakstraderscafe/status/1866423266820448674?s=46

Looking for 7-9 in the short term and beyond that the upside is pretty open back to around 30p

It’s only a matter of time Chris. They’re working away on exciting things such as:

The NCI partnership to validate their flagship technology. We know from the CEO the NCI is putting more resources behind that project so hopefully will get things moving.

The Optiphage work - that project is entering its latter phases I wonder wil the client buy an exclusive licence and FAB get royalty’s on their future projects.

They were using their mammalian display in a different way which was improving quality and yield for their clients exciting valuable assets. Massive potential here for a buyout.

Overall such an exciting time and the market is just waking up to it.

The business is in a much much leaner position, closer to profitability than it was a few years a go with a much more diverse range of clients and excellent new technologys and partnerships. Absolutely no reason it shouldn’t be back north of 50p

Strong performance yesterday, people starting to realise the potential here. Very little stock in issue and people holding this tightly so it’s likely to rise quickly. Looking forward to the CEO presentation on Thursday to a wide range of new investors

It really is. Allenby capital highlighted Absci which has a market cap around $450m and Shard highlighted FJ bio which has valued around €900m as both being highly relevant to how undervalued Fusion is. FAB have around 11 molecules in the clinic and FJ bio have around 14 I believe. They’re both CROs and FABs view is their mammalian display is far superior . It can’t be long until the true value of FAB is realised by the market and it rerates to where it deserves to be.

Think we’ll see that before the interview on Thursday! Hopefully a strong positioning before a great presentation which will hopefully attract some decent new investors

Deservedly so. The share price has been depressed for way too long on false fears of need for a raise. The board have been explicit this ain’t gonna happen.

The margins are up, they were on track and on plan to meet analysts expectations for the year and now they’ve dropped a whopper of an RNS.

I’m excited to see what’s to come next, perhaps news on the USA national cancer institute partnership? The CEO also said the Optiphage project with the large diagnostic company was entering its latter phases. Remember that that client took an option to be able to take an exclusive licence for a fee and fab would get future royalties on antibodies developed by them. That could be huge and potentially soon also.

It’s shocking really that this hasn’t gained more interest.

The company are so close to profitability, they’ve developed and rolled out multiple new class leading proprietary platforms that are ready to go, they’re pivoting their existing tech to make clients assets even more valuable, they’ve increased margins this year to 27% and shard are forecasting this to be back to 39% by year end and 61% by end of next FY, the business is leaner, the NCI partnership is into its second half and hopefully will bring massive news! Plus they’ve a really diverse client base, they’re broadening their markets, they’ve got blue chip clients all over the place who could licence or buyout any of their tech at any point as well as having a pipeline of molecules in the clinic which could generate milestones or royalty payments at any time.

Then, to top it off out of the blue they drop that news about the grant and game changing partnerships last week. That really does tell me the future is bright for FAB.

E

Https://www.sharesoc.org/events/discovery-company-webinar-12-december-500pm/

It really is setup so well for the future. They’re so much leaner and closer to profitability than they were years ago when the share price was over 150p. I’m so excited to see what news comes next, there’s so many angles to this that could come off.

Thabks, was referring to Laura2022s post earlier today tho, felt like a national article?

RE: Big Re Rate ComingToday 09:45

Tipped

According to Telegram UK bio pharmaceutical cos have been tipped for growth in 2025

They list FAB SCLP PYC amongst others due to the labour government £1bln+ commitment to UK life science

Can't find a link sorry

Was this in the telegraph today?

Https://www.sharesoc.org/events/discovery-company-webinar-12-december-500pm/